Key Insider and Institutional Activities at Amgen ($AMGN)
On February 7, 2025, Jonathan P Graham, the Executive Vice President and General Counsel of Amgen ($AMGN), sold 25,045 shares of the company’s stock for approximately $7,341,122. This sale represents about 46.4% of his holdings in that particular class of shares. Following the transaction, he retains 28,987 shares of $AMGN.
In the last six months, insiders at $AMGN have been active, reporting two trades, both of which involved selling shares.
Recent insider transactions include:
- Jonathan P Graham (EVP & Gen. Counsel & Secy.) sold 25,045 shares for approximately $7,341,122
- Nancy A. Grygiel (SVP & CCO) sold 1,589 shares for about $483,807
For more detailed insights into insider transactions, visit Quiver Quantitative’s insider trading dashboard.
Institutional Investors and Amgen
During the most recent quarter, 1,165 institutional investors acquired shares of $AMGN, while 1,369 investors reduced their holdings.
Notable institutional movements include:
- Pathway Financial Advisers, LLC removed 4,446,206 shares (-99.7%) in Q4 2024, totaling approximately $1,158,859,131
- Charles Schwab Investment Management Inc increased their holdings by 2,672,975 shares (+25.4%) in Q4 2024, valued at around $696,684,204
- Bank of America Corp /DE/ decreased their holdings by 1,732,559 shares (-28.7%) in Q3 2024, for approximately $558,247,835
- Primecap Management Co/CA/ sold off 1,253,816 shares (-8.8%) in Q4 2024, totaling around $326,794,602
- Assenagon Asset Management S.A. removed 897,684 shares (-58.3%) from their holdings in Q4 2024, valued at roughly $233,972,357
- Qube Research & Technologies Ltd decreased their position by 813,835 shares (-76.7%) in Q3 2024, totaling about $262,225,775
- Van Eck Associates Corp added 753,147 shares (+263.8%) to their portfolio in Q4 2024, approximately worth $196,300,234
To view further information about hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.
Congressional Activity in Amgen Trading
In the past six months, members of Congress have traded $AMGN shares twice, with one purchase and one sale reported.
For more information on congressional stock trading, visit Quiver Quantitative’s congressional trading dashboard.
This article does not provide financial advice. For more details, refer to Quiver Quantitative’s disclaimers.
This article was initially published on Quiver News; read the full story for more insights.
The opinions expressed in this article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
